NECROVI (Iron sucrose)

NECROVI (Iron sucrose)

NECROVI (Iron sucrose)

NECROVI (Iron sucrose)

NECROVI (Iron sucrose)

NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC.

Address:
Lot E2a-1, E2a-2 Saigon Hitech Park, Long Thanh My Ward, Thu Duc City, Ho Chi Minh City, VIETNAM
Lot I-5C Saigon Hitech Park, Tang Nhon Phu A Ward, Thu Duc City, Ho Chi Minh City, VIETNAM

Tel: (+84) 28 7108 9688

Fax: (+84) 283 730 9963

Email: info@nanogenpharma.com

NECROVI

Home Products NECROVI

NECROVI

COMPOSITION
Each vial of solution for injection (5 mL) contains:
Iron (as Iron sucrose) .......... 100 mg
Excipients: Sodium hydroxide, Water for injection.
PHARMACEUTICAL FORM
Solution for injection
INDICATIONS
Necrovi is indicated for the treatment of iron deficiency in the following cases:
  • Treatment of iron deficiency anemia in patients with kidney disease: for patients on regular dialysis, not on regular dialysis, or on peritoneal dialysis.
  • Treatment of iron deficiency when rapid iron supplementation is necessary.
  • For patients who require iron supplementation but cannot take oral iron, are non-compliant with oral iron therapy, or have inflammatory bowel disease where oral iron is ineffective.
  • Concentrated solution for intravenous infusion
CONTRAINDICATIONS
Necrovi should not be used in the following cases:
  • Hypersensitivity to iron complexes (in mono- or disaccharide form) or any of the drug’s components.
  • Anemia not caused by iron deficiency.
  • Iron overload or disorders in iron utilization.
  • Pregnant women in the first trimester.

Related products

Current product

MIRACEL

Current product

CALITAXEL

Current product

EMILOX

Current product

GLURINAX 600